BARBANTI, PIERO
 Distribuzione geografica
Continente #
NA - Nord America 2.900
AS - Asia 2.060
EU - Europa 540
SA - Sud America 75
Continente sconosciuto - Info sul continente non disponibili 67
AF - Africa 33
OC - Oceania 10
Totale 5.685
Nazione #
US - Stati Uniti d'America 2.454
TR - Turchia 1.049
SG - Singapore 456
CA - Canada 435
CN - Cina 413
IT - Italia 161
IE - Irlanda 71
BR - Brasile 66
EU - Europa 65
UA - Ucraina 63
IN - India 51
RU - Federazione Russa 45
DE - Germania 44
GB - Regno Unito 39
HK - Hong Kong 31
FI - Finlandia 28
NL - Olanda 18
SC - Seychelles 16
ES - Italia 15
FR - Francia 10
JP - Giappone 9
MX - Messico 9
SE - Svezia 9
BD - Bangladesh 8
AU - Australia 7
EG - Egitto 6
IL - Israele 6
PL - Polonia 6
ZA - Sudafrica 6
CL - Cile 5
IR - Iran 5
PK - Pakistan 5
RO - Romania 5
CZ - Repubblica Ceca 4
DK - Danimarca 4
TW - Taiwan 4
VN - Vietnam 4
NO - Norvegia 3
NZ - Nuova Zelanda 3
PH - Filippine 3
PT - Portogallo 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AT - Austria 2
DZ - Algeria 2
HR - Croazia 2
ID - Indonesia 2
KR - Corea 2
MN - Mongolia 2
MT - Malta 2
NP - Nepal 2
RS - Serbia 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
BG - Bulgaria 1
CO - Colombia 1
EC - Ecuador 1
HN - Honduras 1
IQ - Iraq 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
MA - Marocco 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 5.685
Città #
Kocaeli 926
San Mateo 664
Toronto 421
Wilmington 223
Santa Clara 183
Houston 181
Singapore 158
Lawrence 140
Princeton 140
Beijing 102
Ashburn 99
Fairfield 74
Seattle 54
Chandler 49
West Jordan 46
Los Angeles 44
Redwood City 43
Shanghai 38
Woodbridge 34
Rome 30
Hong Kong 29
Guangzhou 26
Cambridge 24
Dublin 24
Helsinki 24
Brooklyn 21
New York 17
Milan 15
Shenzhen 13
Vicenza 13
Munich 11
Suffern 9
São Paulo 9
London 8
Saint Petersburg 8
Andover 7
Rui'an 7
The Dalles 7
Wuhan 7
Boston 6
Charlotte 6
Dallas 6
St Petersburg 6
Wuxi 6
Ann Arbor 5
Borås 5
Jiaxing 5
Mexico City 5
Philadelphia 5
Pune 5
Quanzhou 5
Tokyo 5
Warsaw 5
Washington 5
Xi'an 5
Atlanta 4
Buffalo 4
Columbus 4
Denver 4
Fontebuona 4
Johannesburg 4
Nanjing 4
Nantong 4
Redmond 4
San Francisco 4
Sanming 4
Ankara 3
Carol Stream 3
Chicago 3
Dongyang 3
Florence 3
Gatchina 3
Kiev 3
Kyiv 3
Lisbon 3
Malo 3
Montreal 3
Moscow 3
Murfreesboro 3
Ottawa 3
Perm 3
Phoenix 3
Poplar 3
Rio De Janeiro 3
Rockville 3
Secaucus 3
Taizhou 3
Tampa 3
Algiers 2
Amsterdam 2
Ancona 2
Arce 2
Assago 2
Auckland 2
Belo Horizonte 2
Central District 2
Chengdu 2
Comun Nuovo 2
Council Bluffs 2
Curitiba 2
Totale 4.147
Nome #
Rationale for use of onabotulinum toxin A (BOTOX) in chronic migraine 117
Donepezil in the treatment of hallucinations and delusions in Parkinson's disease 93
A Systems Medicine Clinical Platform for Understanding and Managing Non-Communicable Diseases 88
A case - control study on excessive daytime sleepiness in episodic migraine 76
A case-control study on excessive daytime sleepiness in chronic migraine 76
Look beyond Catechol-O-Methyltransferase genotype for cathecolamines derangement in migraine: the BioBIM rs4818 and rs4680 polymorphisms study 73
Amitriptyline in preventive treatment of tension headaches in non-depressed patients is efficient for chronic, but not for episodic cases 73
A case-control study on excessive daytime sleepiness in chronic migraine 71
Association between migraine and ACE gene (insertion/deletion) polymorphism: the BioBIM study 61
Unilateral cranial autonomic symptoms in migraine 54
Amitriptyline is effective in chronic but not in episodic tension-type headache: Pathogenetic implications 52
Polymorphism at codon 129 or codon 219 of PRNP and clinical heterogeneity in a previously unreported family with Gerstmann-Straussler-Scheinker disease (PrP-P102L mutation) 50
Early (<= 1-h) vs. late (> 1-h) administration of frovatriptan plus dexketoprofen combination vs. frovatriptan monotherapy in the acute treatment of migraine attacks with or without aura: a post hoc analysis of a double-blind, randomized, parallel group study 50
Acupuncture in cluster headache: Four cases and review of the literature 50
Ketogenic diet in migraine: rationale, findings and perspectives 49
Late motor recovery is influenced by muscle tone changes after stroke 49
Prolonged muscular flaccidity after stroke morphological and functional brain alterations 49
Rizatriptan in migraineurs with unilateral cranial autonomic symptoms: a double-blind trial 48
An open study with reversible MAO-A inhibitors in complicated Parkinson's disease 48
A meta-analysis of biomarkers related to oxidative stress and nitric oxide pathway in migraine 48
Acute pathological laughter induced by sumatriptan 48
Dopamine and migraine: Does Parkinson's disease modify migraine course? 48
Treatment of tension-type headache: from old myths to modern concepts 48
Reduced density of dopamine D2-like receptors on peripheral blood lymphocytes in Alzheimer's disease 47
Dopamine hypersensitivity in migraine: Role of the apomorphine test 47
Tardive dyskinesias in the elderly 47
Prolonged muscular flaccidity: frequency and association with unilateral spatial neglect after stroke 47
Clinical features, disease progresson and use of healthcare resoiurces in a large sample of 866 patients from 24 headaches centers: a real-life perspective from the italian chronic migraiNE (IRON) project 47
DOPAMINE BETA HYDROXYLASE (DBH) 19BP INSERTION/DEL POLYMORPHISM INFLUENCES MEDICATION OVERUSE HEADACHE 46
Association between migraine and sod1 and sod2 genes polymorphisms: the biobim study 46
Prolonged muscular flaccidity in stroke patients is associated with crossed cerebellar diaschisis 46
Machine learning approach to predict medication overuse in migraine patients 46
The role of anti-CGRP antibodies in the pathophysiology of primary headaches 45
A mechanism-based classification of pain in multiple sclerosis 45
Efficacy of early vs. late use of frovatriptan combined with dexketoprofen vs. frovatriptan alone in the acute treatment of migraine attacks with or without aura 45
BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study 45
Migraine patients show an increased density of dopamine D3 and D4 receptors on lymphocytes 45
Migraine and movement disorders 45
Differences in short-term primary motor cortex plasticity as assessed by repetitive transcranial magnetic stimulation in migraine with and without aura 45
Cerebral Transverse Sinus Morphology As Detected by MR Venography in Patients With Chronic Migraine 45
Excessive daytime somnolence in Parkinson's disease. Follow-up after 1 year of treatment 44
Cluster headache: management of acute attacks before triptans 44
Dopamine and migraine: does Parkinson's disease modify the course of migraine? 43
Donepezil in the treatment of progressive supranuclear palsy 43
NON-INVASIVE VAGUS NERVE STIMULATION (NVNS) FOR THE ACUTE TREATMENT OF MIGRAINE WITHOUT AURA IN ADOLESCENTS: PRELIMINARY CLINICAL EXPERIENCE 43
Increased expression of dopamine receptors on lymphocytes in Parkinson's disease 43
Real-world insights on the management of migraine patients: an Italian nationwide study 43
Case-control genetic association studies in migraine: a 7-year experience at the Interinstitutional Multidisciplinary Biobank (BioBIM) of IRCCS San Raffaele Pisana 42
Circulating Biomarkers in Migraine: New Opportunities for Precision Medicine 42
Impact of the International Headache Society criteria on the use of neuroimaging for headache diagnosis in a headache clinic 42
Shortened cortical silent period in facial muscles of patients with migraine 41
Comparison of frovatriptan plus dexketoprofen (25mg or 37.5 mg) with frovatriptan alone in the treatment of migraine attacks with or without aura: A randomized study 41
Non-invasive vagus nerve stimulation (nVNS) as symptomatic treatment of migraine in young patients: a preliminary safety study 41
Tension type headache: a neuropsychological and neurophysiological study 41
Pramipexole in Parkinson's disease. A short-term study using the combined levodopa-dopamine agonist test 40
Use of dopamine agonists in aged patients with Parkinson's disease 40
Drugs targeting nitric oxide synthase for migraine treatment 40
Chronic migraine: treatability, refractoriness, pseudo-refractoriness 40
Hypertension as a risk factor for migraine chronification 40
Association of 24-h productivity with 2-h pain-free rates following administration of a fast disintegrating/rapid release formulation of sumatriptan 40
Dopaminergic symptoms in migraine: a case series on 446 consecutive patients 39
Effects of a fast disintegrating/rapid release oral formulation of sumatriptan on functional ability in patients with migraine 39
Migraine attack delays gastric emptying: an ultrasonographic study 39
Trigeminal sensory pathway function in patients with SUNCT 39
Efficacy and Safety of Frovatriptan plus Dexketoprofen in Menstrual Related Migraine (MRM) 39
Impairment of trigeminal sensory pathways in cluster headache 39
Migraine and the extrapyramidal system 39
Establishment of a biorepository for migraine research: the experience of Interinstitutional Multidisciplinary BioBank (BioBIM) 38
Cocaine and headache: a 2-year follow-up study in chronic cocaine users and literature review 38
Prevalence and Time Course of Post-Stroke Pain: A Multicenter Prospective Hospital-Based Study 38
A proposal for a national registry on chronic migraines 38
Open-label Pilot Study of Non-invasive Vagus Nerve Stimulation for the Prevention of Menstrual Migraine and Menstrually Related Migraine 38
Look beyond COMT genotype for cathecolamines derangement in migraine: the biobim rs4818 and rs4680 polymorphisms study 37
Restless legs syndrome is not associated with migraine with aura: a clinical study 37
Non-invasive Vagus Nerve Stimulation (nVNS) as mini-prophylaxis for menstrual/menstrually related migraine: an open-label study 37
Excessive daytime sleepiness in untreated Parkinson's disease patients: Follow-up after 1 year of dopaminergic drug therapy 37
Non-invasive vagus nerve stimulation for acute treatment of high-frequency and chronic migraine: an open-label study 36
Future trends in drugs for migraine prophylaxis 36
Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial 36
Association between Migraine and Progesterone Receptor Gene PROGINS Polymorphism: the BioBIM study 35
Creutzfeldt-Jakob disease and related disorders: Etiopathogenetic aspects 35
HEADACHE FREQUENCY AND CHARACTERISTICS IN CHRONIC COCAINE USERS: A CROSS SECTIONAL STUDY 35
Efficacy of frovatriptan and other triptans in the treatment of acute migraine of hypertensive and normotensive subjects: a review of randomized studies 35
Migraine prophylaxis: what is new and what we need? 35
Migraine and Tourette syndrome 35
Unilateral Cranial Autonomic Symptoms in Migraine: A Retrospective Case Series on 757 Patients 35
The role of dopamine in migraine 35
Pharmacotherapy for acute migraines in children and adolescents 35
Redox mechanisms in migraine: novel therapeutics and dietary interventions 34
CEP Cortelli Corrigendum for 515342 (vol 34, pg 434, 2014) 34
Symptomatic cluster headache following an ischaemic lesion of the trigemino-cervical complex 34
Rational for using SSRI (selective serotonin uptake inhibitors) in migraine prophylaxis 34
No association between essential tremor and migraine: A case-control study 33
Socio-economic costs of migraine 33
Role of neurostimulation in migraine 33
Headache in chronic cocaine users: A cross-sectional study 33
The phenotype of migraine with unilateral cranial autonomic symptoms documents increased peripheral and central trigeminal sensitization. A case series of 757 patients 33
Increased thrombophilic predisposition in premenopausal females with chronic migraine 33
Pharmacological Trials in Migraine: It's Time to Reappraise Where the Headache Is and What the Pain Is Like 33
Genetic bases of the nutritional approach to migraine 33
Totale 4.465
Categoria #
all - tutte 65.579
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.579


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.526 78 64 26 16 49 78 58 35 47 73 940 62
2021/20221.377 18 419 425 6 2 0 103 162 16 200 11 15
2022/2023468 319 8 4 18 16 5 12 16 16 26 22 6
2023/2024387 5 2 9 46 14 52 1 27 0 85 3 143
2024/20251.519 81 221 128 52 86 257 111 107 176 22 39 239
2025/202657 57 0 0 0 0 0 0 0 0 0 0 0
Totale 5.917